Kenneth Westover, M.D., Ph.D., Chief of Lung Radiation Oncology Service
Lung Cancer
New Patient Appointment or 214-645-8525
UT Southwestern Medical Center’s lung cancer program includes a dedicated team that offers a level of expertise unmatched in Dallas and North Texas. We provide our patients with comprehensive, timely, and effective care.
Some of the most groundbreaking achievements in radiation therapy for lung cancer in the past decade have taken place at UT Southwestern. Our physicians have pioneered the use of stereotactic radiation to treat early-stage lung cancer, in some instances changing the medical standard of care for certain patient populations.
Meet Our Team
Shahed Badiyan, M.D.
Meet Dr. Badiyan
Anundip Gill, M.S.N., APRN, FNP-C
Yuanyuan Faith Zhang, M.D., Ph.D.
Lung Clinical Trials
As one of the top academic medical centers in the country and the only National Cancer Institute-designated cancer center in North Texas, we lead and participate in a number of clinical trials aimed at improving the outcomes of patients with cancer. The Department of Radiation Oncology enrolls approximately 200 new patients in clinical trials each year.
Clinical trials are critical in developing new therapies for cancer and can mean having access to new medication, groundbreaking research, and additional clinical care. Our clinical trials team is comprised of radiation oncologists, radiation biologists, clinical research coordinators, quality assurance coordinators, and clinical data specialists.
Therapeutic
Non-Small Cell Cancer
- Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Cancer (NSCLC): A Randomized Phase II/III Trial (STU 042017-024: NRG-LU002). Learn more.
- A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC), the STABLE-MATES Trial (STU 022015-069: JoLT-Ca)
- A Phase III, Randomized, Placebo-Controlled, Double-Blind, Multi-Center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Stage I/II Non-Small Cell Lung Cancer (STU 2019-0858: PACIFIC 4/RTOG-3515)
- A Phase I/II Study of Stereotactic Body Radiation Therapy (SBRT) with or without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC). (STU 2019-1764)
Cancer Cachexia
- A Pilot Study of Ruxolitinib in the Treatment of Cancer Cachexia. (STU 2021-0475)
Non-Therapeutic
- Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (STU 062016-073: Lung SAbR)
- Tissue Procurement and Outcome Collection for Cancer Patients With and Without Cachexia (STU 2019-1390)
If you’re interested in a clinical trial, please talk to your doctor.
Learn more about clinical trials.
Helpful Resources
Our patients share their stories and experiences within the Department of Radiation Oncology at UT Southwestern.
Radiation therapy can sound frightening, but we’re here to guide patients throughout their journey. From our dedicated team of physicians and therapists to dietitians and social services, we can help with any questions or concerns.
We offer a variety of support services to help those with cancer and their families.